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3Abstract
Objectives: Ethnic minority groups in the UK experience marked differences in
cardiovascular disease risk. We investigated differences in arterial central
hemodynamics, stiffness and load in a tri-ethnic population-based cohort.
Methods: 1312 participants (70±6y) underwent echocardiography and measurement
of brachial and central blood pressure to assess central arterial hemodynamics
including central pulse pressure (cPP), arterial stiffness (cPP/stroke volume (SV)),
systemic vascular resistance (SVR) and load (Ea).
Results: Brachial and central systolic blood pressures were similar in all ethnic
groups. Compared to Europeans, cPP, cPP/SV and Ea were higher in South Asians.
In contrast, cPP/SV was lower in African Caribbeans despite higher mean arterial
pressure, higher SVR and higher diabetes prevalence. cPP/SV and Ea remained
significantly higher in South Asians and significantly lower in African Caribbeans
after multivariate adjustment. Diabetes and higher HbA1c were more strongly
associated with higher cPP/SV in South Asians than in Europeans (p
interaction=0.045 and 0.005 respectively); higher HbA1c was also more strongly
associated with increased Ea in South Asians than Europeans (p interaction=0.01).
There was no evidence of an interaction between glycemia and cPP/SV in African
Caribbeans.
Conclusion: Compared to Europeans, South Asians have unfavourable arterial
function. Diabetes and hyperglycemia have a more deleterious effect on cPP/SV and
Ea in South Asians. In contrast African Caribbeans have more favourable arterial
function than Europeans and South Asians. These differences may contribute to the
differential ethnic rates of cardiovascular disease.
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5Introduction
People of South Asian and African Caribbean origin experience marked differences
in cardiometabolic disease compared to people of European origin. Both ethnic
minority groups are more insulin resistant, and have a 3-4 fold excess of diabetes.(1)
Stroke mortality is almost doubled in both South Asians and African Caribbeans, but,
while coronary heart disease (CHD) mortality is elevated in South Asians, African
Caribbeans experience CHD mortality rates that are 50% lower than the comparator
European population despite the higher rates of diabetes.(2) This marked ethnic
difference is unexplained by conventional risk factors.(2)
Elevated blood pressure (BP) is a major risk factor for CHD and stroke.(3)
Hypertension is more prevalent in African-Caribbean populations,(4) but observed
differences in brachial BP do not appear to account for the nearly twofold excess of
stroke and cannot explain lower rates of CHD. (2, 5) In contrast, differences in
brachial BP between South Asians and Europeans are generally small and
inconsistent(6). Recent evidence indicates that central (aortic) systolic or pulse
pressure and increased arterial stiffness predict CHD and stroke independently of
brachial BP. (7, 8) Central hemodynamics, aortic stiffness and arterial load may
therefore better explain ethnic differences in cardiovascular risk. Previous studies of
arterial stiffness in South Asian or African Caribbean people have often been
restricted to clinic or hospital populations, with relatively small numbers.(9-15)
Information on ethnic differences in central hemodynamics is also incomplete. A
recent study which pooled central augmentation index (AIx) values from 5 separate
studies reported that African Americans and Andean Hispanics had higher, whereas
American Indians had lower AIx than British whites or Chinese people.(16) However
this analysis of ethnic haemodynamic differences was limited by the differing
6methodologies used to measure central pressure, and the diverse geographical
settings.
We therefore investigated UK-based ethnic differences in central hemodynamics,
arterial stiffness and arterial load as a potential explanation of ethnic differences in
CHD risk. We also explored the potential role of diabetes/hyperglycaemia in any
differences observed in ethnic minority groups.
Methods
Study Population
Participants were recruited from clinic attendees for the 20 year follow-up visit for the
Southall and Brent REvisited (SABRE) study, a tri-ethnic population-based cohort
consisting of white European, first generation migrant South Asian and African
Caribbean men and women. Details of the cohort have been published (17) .
Participants were recruited from primary care between 1988 -1991, when they were
aged 40-69 years. 4857 participants took part in the original study (2346 Europeans,
1710 South Asians and 801 African Caribbeans). Surviving participants were invited
to attend the 20 year follow-up investigation between 2008 and 2011 when they were
aged 58 to 86y. 1438 participants attended for follow-up investigation. A detailed
account of the SABRE cohort at follow-up is given in Online Figure 1 in the online-
only Data Supplement. Approval was obtained from the local research ethics
committee and all participants gave written informed consent, including consent to
primary care record review. Follow-up clinic attendees were as a group healthier
than the entire cohort at baseline; however we have shown that survival rates and
7baseline heath of clinic attendees were similar by ethnicity (2) as shown in Online
Table 1 in the online-only Data Supplement.
Investigations
Participants fasted and refrained from alcohol, smoking and caffeine intake for at
least 12h prior to attendance and omitted any medication on the morning of
investigation. A questionnaire was completed which detailed health behaviours,
medical history and medication.
Clinic measurements
Height, weight, waist and hip circumference and blood pressure were measured
under standardised conditions.(17) Fasting samples were analysed for blood
glucose, glycosylated haemoglobin (HbA1c), insulin, triglycerides, total cholesterol
(TC) and high density lipoprotein (HDL-C) cholesterol. The homeostasis model
assessment of insulin resistance (HOMA-IR) was calculated.(18) Diabetes was
diagnosed on the basis of patient or GP report or clinic blood samples according to
the 1999 World Health Organisation guidelines.(19) Diabetes duration was
established by GP report or from questionnaire. CHD was defined as a coronary
event or revascularisation identified by medical record review, and adjudicated by an
independent committee.
Seated brachial systolic (bSBP) and diastolic (DBP) blood pressure was measured
after 10 minutes rest as the mean of the final two of three readings using a validated
brachial blood pressure device (Omron 705CP). Hypertension was defined as
physician diagnosed hypertension or participant reported hypertension in people
receiving blood pressure (BP) lowering medication. Central hemodynamics were
8measured using a SphygmoCor device (AtCor, Sydney, Australia) (20). Radial artery
pressure was calibrated to bSBP and DBP according to the manufacturer’s
instructions. Central systolic BP (cSBP), mean arterial pressure (MAP), central pulse
pressure (cPP), augmentation index (AIx), augmentation pressure (Paug), end-systolic
BP and central to brachial pulse pressure amplification (PPAmp) were calculated.
Carotid to femoral pulse wave velocity (cfPWV) was measured in accordance with a
recent consensus document(21) using a continuous wave directional Doppler probe
(Micro-Medical Pulse Trace 2000 system). Due to an equipment breakdown, cfPWV
was only measured in 960 individuals (442 Europeans, 349 South Asians and 169
African Caribbeans).
Transthoracic echocardiography was performed as previously described. (22) In
brief, data sets were acquired over 4 cardiac cycles during held respiration using a
5.0-1.0Hz phased array transducer (S5-1) on a Philips iE33 ultrasound device and
analysed using Philips Qlab 7.0. End diastolic (EDV) and systolic volume (ESV) were
used to calculate stroke volume (SV). Ejection fraction (EF) was calculated as
EF=(SV/EDV) *100. Systemic vascular resistance (SVR) was calculated as mean
arterial pressure (mmHg)/cardiac output (ml/min) × 8. While cfPWV is considered the
‘gold standard’ measure of arterial stiffness we additionally calculated the elasticity
coefficient, (the ratio of central pulse pressure to stroke volume, cPP/SV, i.e. the
inverse of total arterial compliance).(23) Total arterial elastance (Ea) a measure of
overall arterial load(24) was calculated as the ratio of end systolic pressure to SV.
9Statistical analysis
Data are reported as mean±SD or median (interquartile range) for skewed data and
n (%) for categorical data. Skewed data were natural log (ln) transformed before
analysis. Statistical analyses were performed using Stata 12.0 (StatCorp LP, Tx).
Comparisons of ethnic groups were made using analysis of variance or covariance
(ANOVA or ANCOVA) followed by post-hoc testing if p< 0.05 by ANOVA.
Multivariable regression was also performed: covariates (age, sex, height, waist hip
ratio (WHR), heart rate, MAP, BP treatment, TC:HDL-C ratio, diabetes, HOMA-IR
CHD and smoking were chosen a priori based on their known influence on arterial
function. Possible interactions by gender and diabetes status were sought and data
from both sexes were pooled, with adjustment for sex in all multivariable models.
Separate sex results can be found in Online Tables 2-4 in the online-only
supplement. A p value of <0.05 was considered statistically significant.
Results
Characteristics of participants are shown in Table 1. South Asian and African
Caribbean people were more likely to have hypertension and diabetes than
Europeans. South Asians had higher prevalence rates of CHD and were more
centrally obese; African-Caribbeans had higher BMI and a lower prevalence of CHD
compared to both Europeans and South Asians. Brachial and central
hemodynamics and measures of arterial elasticity/stiffness (cPP/SV, cfPWV) and
load (Ea) are presented in Table 2. After adjusting for age and sex, both bSBP and
cSBP were slightly higher in African Caribbeans. DBP was significantly lower in
South Asians and higher in African Caribbeans compared to Europeans;
consequently compared with Europeans, bPP and cPP were higher in South Asians,
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and lower in African Caribbeans than Europeans. In contrast, MAP was equivalent in
South Asians, but higher in African Caribbeans, than Europeans. AIx and Paug were
significantly higher in South Asians but did not differ in African-Caribbeans compared
to Europeans. There was no significant inter-ethnic difference in Pamp. SVR was
higher in South Asians and African Caribbeans compared to Europeans. Compared
to Europeans, cPP/SV was significantly higher in South Asians and lower in African
Caribbeans (Table 2); these differences were also maintained after indexation of
cPP/SV to body surface area (not shown). Ea was higher in South Asians and similar
in African Caribbeans compared to Europeans. cfPWV was slightly lower in African
Caribbeans but not significantly so. When cPP/SV was compared in only those
participants in whom cfPWV was measured it remained significantly different by
ethnicity (European = 0.83±0.01; South Asian = 0.95±0.02; African-Caribbean
=0.81±0.02; p <0.001 by ANCOVA and p<0.001 for comparison between Europeans
and South Asians).
To seek explanations for these ethnic differences, further multivariate analysis was
performed. After additionally adjusting for height, WHR, BP treatment, MAP,
TC:HDL-C, diabetes, HOMA-IR, CHD and smoking (Table 3), differences in PP, cPP
and Paug between Europeans and South Asians were attenuated and became non-
significant. In contrast, the greater SVR, cPP/SV and Ea in South Asians versus
Europeans remained significant after multivariable adjustment. After multivariable
adjustment bSBP, bPP, cSBP cPP, AIx, PAug and cPP/SV were significantly lower
and DBP remained significantly higher in African Caribbeans.
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Ethnicity as a modifier of the effect of diabetes on arterial function
Given the high prevalence of diabetes and its known effect on arterial function, we
explored whether ethnicity modified the associations between diabetes and
measures of arterial hemodynamics, stiffness (cPP/SV) and load (Ea). Diabetes or
elevated HbA1c was found to exert a more detrimental effect on cPP/SV and Ea in
South Asians than Europeans (Figure 1) in models adjusted for age and sex. Further
adjustment for height, WHR, MAP, BP treatment, heart rate, TC:HDL-C, CHD and
smoking had minimal effects on these interactions and there was no interaction
between ethnicity and insulin resistance assessed as HOMA-IR on measures of
arterial hemodynamics, cPP/SV and Ea (data not shown).
Association of arterial resistance, stiffness and load with CHD
Using logistic regression we investigated the association of SVR, , cPP/SV, cfPWV
and Ea with CHD. Associations are presented as age, sex and ethnicity adjusted
standardised odd ratios [95%] confidence intervals in Online Table 5 in the online-
only Data Supplement. cPP/SV was the most strongly associated variable with CHD
(0.26 [0.10,0.41], p=0.002), followed by cfPWV (0.17 [0.02,0.3], p=0.03). SVR and
Ea were not significantly associated with CHD (SVR (0.008 [-0.14,0.16], p=0.9) and
Ea (0.06 [-0.09,0.21], p=0.5)).
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Discussion
In this tri-ethnic population-based study in the UK, we show marked inter-ethnic
differences in central arterial BP, vascular resistance (SVR), stiffness (cPP/SV) and
arterial load (Ea). After adjustment for known risk factors, people of South Asian
origin still had unfavourable SVR, cPP/SV and Ea. In contrast, people of African
Caribbean origin had more favourable cPP/SV than Europeans but had higher mean
arterial pressure and elevated SVR. We also found that diabetes/hyperglycaemia
was associated with worse cPP/SV and Ea in South Asians than Europeans.
Little is known regarding arterial central hemodynamics, stiffness and load in South
Asian people. Two small UK-based studies(12, 15) have previously reported that
PWV is higher in South Asians. In the main analysis we did not observe a significant
difference in cfPWV between ethnic groups, although cPP/SV was elevated. When
we stratified by sex we observed significantly higher cfPWV in South Asian women
and lower cfPWV in African Caribbean women (online Tables 3 and 4) but we did not
see this pattern in men. The difference between the two arterial stiffness measures
in men (cfPWV and cPP/SV) may reflect the smaller numbers of participants in
whom cfPWV was measured, or the inability of cfPWV to assess stiffening of the
proximal aorta(25). The latter explanation is more likely in view of the preserved
difference in cPP/SV in the sub-sample in whom cfPWV was measured. The results
presented in online Table 4 show that cPP/SV is more strongly associated with CHD
than cfPWV which suggests that cfPWV may have more limited prognostic value in
elderly individuals.
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A previous study(14) showed that an indirect measure of arterial stiffness was
elevated in South Asian stroke survivors compared with Europeans. This difference
was explained by the higher stiffness index in South Asian people with diabetes,
although an interaction between ethnicity and diabetes was not looked for. This
finding in a highly selected sample is consistent with our observation of greater
stiffness and a more adverse effect of diabetes on aortic stiffness in a population-
based sample of South Asians, despite similar hypertension treatment rates and
MAP. We also show that the adverse effects of hyperglycaemia on stiffness and
load are not confined to people with diabetes, but extend across the glycaemic
spectrum as measured by HbA1c.
In contrast, despite similarly high rates of medication for hypertension, African
Caribbeans had elevated BP (DBP and MAP), and higher SVR, yet did not have
unfavourable arterial central hemodynamics, stiffness (cfPWV) and load (Ea). This is
consistent with some(9), but not all(11), previous UK findings. Most previous work
comparing Black African-origin with White European-origin populations has been
undertaken in the US. These studies, have generally found higher central BP in
African Americans, although findings with regard to arterial stiffness are less
consistent. Birru et al (26) reported that PWV was higher in African American
women, but the Multi-Ethnic Study of Atherosclerosis also failed to find any
difference in large arterial elasticity in African Americans compared to White,
Hispanic or Chinese Americans, although small artery elasticity was increased(13).
We observed the opposite to Birru, the favourable hemodynamic pattern observed in
African Caribbean women was reflected in a lower cfPVW . It may be relevant to
note that the situation is different in America. Since the 1970’s African Americans
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have been observed to be at higher risk of CHD than White Americans(27), unlike
the UK where African Caribbeans are at lower risk of CHD than Europeans(2).
We interpret our findings in the light of known ethnic differences in risks of CHD. Our
group has previously reported that rates of CHD are elevated in South Asians and
are lower in African Caribbeans compared with European-origin populations and that
these differences were not explained by conventional risk factors. Table 4
summarises the ethnic differences in cardiovascular/hemodynamic risk factors in
South Asians and African Caribbeans compared to Europeans. We propose that
differences in arterial hemodynamics/stiffness could play a role in explaining these
ethnic differences. Arterial stiffness predicts CHD independently of conventional risk
factors including mean BP.(28-30). Increased arterial stiffness reduces the
capacitative buffering (Windkessel) effect of the aorta, increases the hemodynamic
afterload imposed on the LV, effects myocardial blood flow, increases myocardial
oxygen demand, and increases susceptibility to sub-endocardial ischemia.(31) This
explanation is consistent mechanistically with the known ethnic differences in CHD.
Increased arterial stiffness could contribute to increased rates of CHD observed in
South Asians, while favourable arterial haemodynamics/stiffness would explain the
lower rates of CHD observed in African Caribbeans.
Our findings therefore also provide a potential mechanism to explain why diabetes
and hyperglycemia are particularly adverse for risk of CHD in South Asian people(2)
since they are associated with greater arterial stiffness in South Asian people than in
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Europeans or African-Caribbean people. Diabetes and hyperglycemia have been
reported to be associated with increased arterial stiffness,(32) although the strength
of association has previously been reported as weak,(33) and we observed no
significant relationship between diabetes or glycosylated haemoglobin in Europeans
or African Caribbeans in this study. It is possible that more aggressive management
of BP in people with diabetes contributes to this effect. The effect of diabetes on
arterial stiffness has been attributed to increased oxidative stress, impaired
endothelial function, accelerated fibrosis and accumulation of advanced glycation
end products (AGEs) in the vasculature. Why diabetes and hyperglycaemia should
exert a more deleterious effect on arterial stiffness in South Asians is uncertain. We
have shown that South Asians are diagnosed at a younger age and have greater
diabetes duration; moreover we know that individuals experience years of
hyperglycaemia before diabetes diagnosis.(34) Given our observation that the
greater impact of hyperglycaemia on stiffness occurs across the glycaemic
spectrum, it is likely that South Asians are exposed to greater levels of
hyperglycaemia over much longer periods, resulting in more adverse effects on the
vasculature, although it is unclear why this effect would not be apparent in African
Caribbeans who also experience an increased risk and duration of diabetes.(1) It is
possible that other mechanisms acting in South Asian people, such as worse
endothelial function(14) and/or a higher pro-inflammatory background (35)
contribute, but further studies are required to investigate this question.
SABRE is one of the largest and longest running multi-ethnic studies worldwide.
Participants were recruited from primary care without exclusion, thereby minimising
selection bias at the outset of the study. As mentioned in the methods section, this
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follow-up study was limited to survivors who were willing and able to attend clinic.
Clinic attendees were healthier at baseline than those who did not survive or failed to
attend; however we have shown that survival rates and baseline heath of clinic
attendees were similar by ethnicity(2), so this limitation is unlikely to have biased
comparisons. A further limitation is that the majority of South Asians in this study
(53%) are of Punjabi Sikh origin, and although most people of South Asian ethnicity
have an increased prevalence of diabetes and CVD, our findings may not apply to all
South Asians. Similarly, our findings cannot necessarily be extrapolated to people of
South Asian or African Caribbean ethnicity living outside the UK, people outside the
age range studied, or to second or third-generation migrants. A final limitation is the
calculation of our arterial elasticity coefficient, while SV is directly calculated by
echocardiography cPP is indirectly estimated.
In conclusion, compared to Europeans, South Asians have unfavourable arterial
function and diabetes and hyperglycemia have a more deleterious effect on arterial
stiffness and load. In contrast, African Caribbeans have more favourable arterial
stiffness than Europeans and South Asians despite higher BP and higher SVR.
These differences may contribute to the differential ethnic rates of cardiovascular
disease.
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Figure legends
Figure 1: Bar charts showing A) cPP/SV and B) Ea categorized by diabetes status
and ethnicity. P values are for significant ethnicity x diabetes interactions. Linear
regression between C) cPP/SV and D) Ea and HbA1c in Europeans South Asians,
and African Caribbeans; points and confidence intervals have been omitted for
clarity. All values adjusted for age and sex. P values are for significant ethnicity x
HbA1c interactions.
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Table 1: Participant characteristics
European
n= 589
South Asian
n= 459
African
Caribbean
n=214
P value
Male, n (%) 457 (78) 388 (85) ** 110 (51) ** <0.001
Age, y 69.7±6.2 69.0±6.1 70.1±5.9¶ 0.03
Height, cm) 170±9 166±9** 165±9** <0.001
BMI, kg/m2 27.9±5 26.3±4** 29.2±6**¶¶ <0.001
Waist-hip ratio 0.97±0.08 1.00±0.07** 0.96±0.08¶¶ <0.001
Hypertension, n (%) 336 (57) 346 (75) ** 169 (79) ** <0.001
Receiving
antihypertensive
medication, n (%)
321 (55) 343 (75)** 163 (76)** <0.001
Diabetes, n, (%) 112 (19) 186 (41) ** 88 (41) ** <0.001
Diabetes duration, y 5 (0,10) 9 (2, 19)* 9 (14,19)** 0.02
On diabetes
medication
62 (11) 136 (30)** 68 (32)** <0.001
On lipid lowering
medication
281 (48) 308 (67)** 109 (51) <0.001
CHD, n (%) 118 (20) 159 (35) ** 27 (13)* <0.001
Ejection fraction, % 61 (10) 62(9) 64 (9)**¶¶ <0.001
TC:HDL-C 3.50(2.9,4.2) 3.42 (2.8,4.2) 3.25(2.6,3.8)*¶¶ <0.001
Triglycerides,
mmol/l
1.18 (0.9,1.6) 1.19 (0.9,1.6) 0.88 (0.7,1.1)**¶¶ <0.001
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Data are mean ± SD or median ( 25th-75th percentile for skewed data) for numerical
data and n (%) for categorical data. BMI, body mass index; HbA1c, glycosylated
haemoglobin; HOMA-IR, homeostasis model assessment of insulin resistance;
TC:HDL-C, total cholesterol: high density lipoprotein cholesterol ratio.
*p<0.05,**p<0.01 compared to Europeans; ¶ p<0.05, ¶¶ p<0.01 African Caribbeans,
compared to South Asians by post-hoc test after ANOVA.
HbA1c, %
[mmol/mol]
5.9 (5.6,6.2)
[41(38, 44)]
6.2 (5.9,6.9)**
[44(41, 52)]
6.2 (5.9,6.9)**
[44(41, 52)]
<0.001
HOMA-IR 1.10 (0.7,1.7) 1.30 (0.8,2.0) 1.00 (0.7,1.5) 0.3
Smokers, n (%) 47 (8) 18 (4) ** 12 (6) **¶¶ <0.001
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Table 2: Ethnic differences in arterial hemodynamics, stiffness and load
Measure European South Asian African
Caribbean
p
ANCOVA
bSBP, mmHg 141.5±0.7 142.4±0.8 143.7±1.1 0.2
DBP, mmHg 84.7±0.4 82.8±0.5** 88.0±0.7**¶¶ <0.001
bPP, mmHg 56.8±0.5 59.6±0.6** 55.7±0.9¶¶ <0.001
MAP, mmHg 104.3±0.5 103.4±0.5 106.6±0.8**¶¶ 0.004
HR, bpm 65.1±0.5 63.3±0.5* 62.6±0.8** 0.005
cSBP, mmHg 132.1±0.6 133.5±0.7 134.4±1.1 0.1
cPP, mmHg 46.6±0.5 58.0±0.6** 45.6±0.9¶¶ <0.001
AIx, % 29.8±0.4 31.8±0.5** 29.7±0.7¶ <0.001
PAug, mmHg 14.5±0.3 16.5±0.3** 14.1±0.5¶¶ <0.001
PPAmp, mmHg 10.2±0.2 9.6±0.2 10.1±0.3 0.1
SVR, MPa·s/m3 226±3 244±3** 236±5¶ <0.001
cPP/SV, mmHg/ml 0.86±0.01 0.97±0.02** 0.80±0.02*¶¶ <0.001
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Ea, mmHg/ml 2.29±0.03 2.48±0.03** 2.28±0.05¶ 0.004
ln cfPWV,
[geometric mean] m/s
2.40±0.01
[11.5]
2.39±0.01
[11.3]
2.36±0.02
[10.9]
0.3
Data are mean ± SE adjusted for age and sex. [brachial systolic (bSBP) and diastolic
(DBP) blood pressure, brachial pulse pressure (bPP), mean arterial pressure (MAP),
Heart rate (HR), central systolic BP (cSBP), central pulse pressure (cPP),
augmentation index (AIx), augmentation pressure (Paug), central to brachial pulse
pressure amplification (PPAmp) ,Systemic vascular resistance (SVR), Arterial
stiffness/elasticity coefficient,( cPP/SV), total arterial elastance (Ea), carotid to
femoral pulse wave velocity (cfPWV). *p<0.05,**p<0.01 compared to Europeans; ¶
p<0.05, ¶¶ p<0.01 African Caribbeans, compared to South Asians by post-hoc test
after ANOVA.
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Table 3: Ethnic differences in arterial hemodynamics, stiffness and load after
multivariable adjustment.
Measure European South Asian African
Caribbean
p
ANCOVA
bSBP, mmHg 142.3±0.4 142.5±0.4 140.4±0.6**¶¶ 0.02
DBP, mmHg 84.3±0.2 84.1±0.2 86.3±0.3**¶¶ <0.0001
bPP, mmHg 58.1±0.5 58.4±0.6 54.1±0.8**¶¶ 0.0001
cSBP, mmHg 133.1±0.3 133.7±0.3 131.0±0.5**¶¶ <0.0001
cPP, mmHg 48.1±0.4 48.8±0.5 43.8±0.7**¶¶ <0.0001
AIx, % 30.6±0.3 31.3±0.4 29.0±0.6*¶¶ 0.004
PAug, mmHg 15.4±0.2 15.9±0.3 13.1±0.4**¶¶ <0.0001
PPAmp, mmHg 10.0±0.2 9.6±0.2 10.3±0.3¶ 0.1
SVR¥, MPa·s/m3 228±3 244±3** 232±5 0.004
cPP/SV, mmHg/ml 0.88±0.01 0.95±0.02** 0.79±0.02**¶¶ <0.0001
Ea, mmHg/ml 2.29±0.03 2.47±0.03** 2.27±0.05¶¶ 0.0006
Logn cfPWV,
[geometric mean] m/s
2.40±0.01
[11.6]
2.38±0.02
[11.3]
2.35±0.02
[11.0]
0.2
Data are mean ± SE adjusted for age, sex, height, waist hip ratio, mean arterial
pressure, antihypertensive treatment, heart rate, total:high density lipoprotein
cholesterol, diabetes, HOMA-IR ,diagnosed coronary heart disease and smoking. ¥
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mean arterial pressure omitted from model. Abbreviations as in table 2.
*p<0.05,**p<0.01 compared to Europeans ; ¶ p<0.05, ¶¶ p<0.01 African Caribbeans,
compared to South Asians by post-hoc test after multivariable regression.
Table 4: Symbolic summary table comparing cardiovascular risk parameters in
South Asians and African Caribbeans to Europeans
Age and sex adjusted Fully adjusted
South
Asian
African
Caribbean
South
Asian
African
Caribbean
Diabetes - -
CHD - -
Stroke - -
Hypertension - -
bSBP/cSBP
DBP
MAP - -
bPP/cPP
AIx
PAug
PPAmp
SVR
cPP/SV
Ea
cfPWV
Fully adjusted model: age, sex, height, waist hip ratio, mean arterial pressure,
antihypertensive treatment, heart rate, total:high density lipoprotein cholesterol,
diabetes, HOMA-IR, diagnosed coronary heart disease and smoking. Abbreviations
as in table 2

